Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Simple item page
dc.contributor.authorGoey, K.K.H.
dc.contributor.authorSørbye, H.
dc.contributor.authorGlimelius, B.
dc.contributor.authorAdams, R.A.
dc.contributor.authorAndré, T.
dc.contributor.authorArnold, D.
dc.contributor.authorBerlin, J.D.
dc.contributor.authorBodoky, G.
dc.contributor.authorde Gramont, A.
dc.contributor.authorDíaz-Rubio, E.
dc.contributor.authorEng, C.
dc.contributor.authorFalcone, A.
dc.contributor.authorGrothey, A.
dc.contributor.authorHeinemann, V.
dc.contributor.authorHochster, H.S.
dc.contributor.authorKaplan, R.S.
dc.contributor.authorKopetz, S.
dc.contributor.authorLabianca, R.
dc.contributor.authorLieu, C.H.
dc.contributor.authorMeropol, N.J.
dc.contributor.authoret al.
dc.date.issued2018
dc.descriptionAvailable online 22 June 2018
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityKaitlyn K.H. Goey ... Timothy J. Price ... et al.
dc.identifier.citationEuropean Journal of Cancer, 2018; 100:35-45
dc.identifier.doi10.1016/j.ejca.2018.05.010
dc.identifier.issn0959-8049
dc.identifier.issn1879-0852
dc.identifier.orcidPrice, T.J. [0000-0002-3922-2693]
dc.identifier.urihttp://hdl.handle.net/2440/115003
dc.language.isoen
dc.publisherElsevier
dc.rights© 2018 Elsevier Ltd. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.ejca.2018.05.010
dc.subjectColorectal cancer
dc.subjectMetastatic disease
dc.subjectPatient characteristics
dc.subjectPrognosis
dc.subjectStratification
dc.subjectClinical trials
dc.subjectDelphi survey
dc.titleConsensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications